HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Gianni D. Angelini Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Soyombo, A. A. Articles by Newby, A. C. Search for Related Content PubMed PubMed Citation Articles by Soyombo, A. A. Articles by Newby, A. C.

J Thorac Cardiovasc Surg 1995;109:2-12
© 1995 Mosby, Inc.

SURGERY FOR ACQUIRED HEART DISEASE

Neointima formation is promoted by surgical preparation and inhibited by cyclic nucleotides in human saphenous vein organ cultures

Cardiff, Wales, and Bristol, England

Supported by grants from the British Heart Foundation.

Received for publication Jan. 28, 1994. Accepted for publication May 25, 1994. Address for reprints: Andrew Newby, PhD, Department of Cardiology, University of Wales College of Medicine, Heath Park, Cardiff CF4 4XN, Wales.

Abstract

Intimal thickening is an important cause of late coronary vein graft occlusion, which no variation of surgical technique or pharmacologic intervention has been shown to reduce. We used a recently developed quantitative organ culture of human saphenous vein to investigate whether surgical preparative injury promotes neointima formation. We also investigated the effects on neointima formation of the lipid-soluble cyclic nucleotide analogs, 8-Br-cyclic adenosine monophosphate and 8-Br-cyclic guanosine monophosphate, and the phosphodiesterase inhibitor, isobutylmethylxanthine. These agents are pharmacologic mimetics of endothelium-derived prostacyclin and nitric oxide, which elevate vascular smooth muscle cyclic adenosine monophosphate and cyclic guanosine monophosphate concentrations, respectively, and may normally suppress neointima formation. Surgical preparation was found to promote intimal thickening and neointimal smooth muscle cell proliferation by 42% and 48%, respectively. 8-Br-cyclic adenosine monophosphate, 8-Br-cyclic guanosine monophosphate, or isobutylmethylxanthine (which elevated endogenous cyclic adenosine monophosphate concentrations) inhibited intimal thickening by 80%, 40%, and 72%, respectively, at a concentration of 0.1 mmol/L. The results imply that surgical techniques that avoid preparative injury and vasodilator drugs that act by elevating cyclic adenosine monophosphate or cyclic guanosine monophosphate concentrations may reduce neointima formation in vein grafts. (J THORACIC CARDIOVASC SURG 1995;109:2-12)

This article has been cited by other articles:

				T. S. Monahan, N. D. Andersen, M. C. Martin, J. Y. Malek, G. V. Shrikhande, L. Pradhan, C. Ferran, and F. W. LoGerfo MARCKS silencing differentially affects human vascular smooth muscle and endothelial cell phenotypes to inhibit neointimal hyperplasia in saphenous vein FASEB J, February 1, 2009; 23(2): 557 - 564. [Abstract] [Full Text] [PDF]

				A. Momin, N. Melikian, S. B. Wheatcroft, D. Grieve, L. C. John, A. El Gamel, M. T. Marrinan, J. B. Desai, C. Driver, R. Sherwood, et al. The association between saphenous vein endothelial function, systemic inflammation, and statin therapy in patients undergoing coronary artery bypass surgery J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 335 - 341. [Abstract] [Full Text] [PDF]

				M. Bond, G. B. Sala-Newby, and A. C. Newby Focal Adhesion Kinase (FAK)-dependent Regulation of S-phase Kinase-associated Protein-2 (Skp-2) Stability: A NOVEL MECHANISM REGULATING SMOOTH MUSCLE CELL PROLIFERATION J. Biol. Chem., September 3, 2004; 279(36): 37304 - 37310. [Abstract] [Full Text] [PDF]

				R. Lorusso, S. Pentiricci, R. Raddino, T. M. Scarabelli, C. Zambelli, V. Villanacci, A. Burattin, G. Romanelli, S. Casari, R. Scelsi, et al. Influence of Type 2 Diabetes on Functional and Structural Properties of Coronary Artery Bypass Conduits Diabetes, November 1, 2003; 52(11): 2814 - 2820. [Abstract] [Full Text] [PDF]

				C. M Aguilera, S. J George, J. L Johnson, and A. C Newby Relationship between type IV collagen degradation, metalloproteinase activity and smooth muscle cell migration and proliferation in cultured human saphenous vein Cardiovasc Res, June 1, 2003; 58(3): 679 - 688. [Abstract] [Full Text] [PDF]

				E. A. Black, T. J. Guzik, N. E.J. West, K. Campbell, R. Pillai, C. Ratnatunga, and K. M. Channon Minimally invasive saphenous vein harvesting: effects on endothelial and smooth muscle function Ann. Thorac. Surg., May 1, 2001; 71(5): 1503 - 1507. [Abstract] [Full Text] [PDF]

				A. Hammerer-Lercher, J. Mair, J. Bonatti, S. B.C. Watzka, B. Puschendorf, and S. Dirnhofer Hypoxia induces heat shock protein expression in human coronary artery bypass grafts Cardiovasc Res, April 1, 2001; 50(1): 115 - 124. [Abstract] [Full Text] [PDF]

				D. G. Cable, J. A. Caccitolo, N. Caplice, T. O’Brien, R. D. Simari, R. C. Daly, J. A. Dearani, C. J. Mullany, T. A. Orszulak, and H. V. Schaff The Role of Gene Therapy for Intimal Hyperplasia of Bypass Grafts Circulation, November 9, 1999; 100 (2009): II-392 - II-396. [Abstract] [Full Text] [PDF]

				J. Y. Jeremy, D. Rowe, A. M. Emsley, and A. C. Newby Nitric oxide and the proliferation of vascular smooth muscle cells Cardiovasc Res, August 15, 1999; 43(3): 580 - 594. [Full Text] [PDF]

				J. Chanda, R. Kuribayashi, K.-X. Liu, and Y. Shibata Inhibitory effect of photooxidation on intimal and medial thickening of saphenous vein Ann. Thorac. Surg., August 1, 1998; 66(2): 449 - 454. [Abstract] [Full Text] [PDF]

				A. H Baker, D. Mehta, S. J George, and G. D Angelini Prevention of vein graft failure: potential applications for gene therapy Cardiovasc Res, September 1, 1997; 35(3): 442 - 450. [Abstract] [Full Text] [PDF]

				P. B. Canham, H. M. Finlay, and D. R. Boughner Contrasting structure of the saphenous vein and internal mammary artery used as coronary bypass vessels Cardiovasc Res, June 1, 1997; 34(3): 557 - 567. [Abstract] [Full Text] [PDF]

				J.-A. Yang and G.-W. He Surgical Preparation Abolishes Endothelium-Derived Hyperpolarizing Factor-Mediated Hyperpolarization in the Human Saphenous Vein Ann. Thorac. Surg., February 1, 1997; 63(2): 429 - 433. [Abstract] [Full Text]

				J. L. Myers, J. J. Wizorek, A. K. Myers, M. O'Donoghue, M. T. Pettit, P. C. Kouretas, H. J. Dalton, Y. Wang, and R. A. Hopkins MATURATION ALTERS THE PULMONARY ARTERIAL RESPONSE TO HYPOXIA AND INHALED NITRIC OXIDE IN THE PRESENCE OF ENDOTHELIAL DYSFUNCTION J. Thorac. Cardiovasc. Surg., February 1, 1997; 113(2): 270 - 277. [Abstract] [Full Text]

				G. D. Angelini, M. B. Izzat, A. J. Bryan, and A. C. Newby EXTERNAL STENTING REDUCES EARLY MEDIAL AND NEOINTIMAL THICKENING IN A PIG MODEL OF ARTERIOVENOUS BYPASS GRAFTING J. Thorac. Cardiovasc. Surg., July 1, 1996; 112(1): 79 - 84. [Abstract] [Full Text]